Avience Biomedicals Peer Comparison

NSE: AVIENCE

₹250.00

₹-5.00 (-1.96%)

As on 06-Nov-2026IST

Market cap

₹137 Cr

Revenue (TTM)

₹53 Cr

P/E Ratio

15.7

P/B Ratio

2.2

Div. Yield

0 %

Edit

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Market cap (₹ Cr)	137	16,293	1,194	732	326
Revenue (₹ Cr)	53	2,134	342	116	183
Net Profit (₹ Cr)	8.75	309.79	55.72	12.29	12.72
Net Margin (%)	16.58	13.89	16.04	10.59	6.90
RoE (%)	32.37	9.92	25.55	11.80	10.39
Price to Earnings	15.67	51.18	21.42	59.53	29.96
Price-To-Book	2.22	4.99	2.45	5.24	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Operating Revenue	52.51	1,875.26	341.74	115.51	152.30
Total Income	52.80	2,002.19	347.44	116.04	152.65
Total Expenditure	37.41	1,436.66	243.64	93.29	131.80
EBITDA	15.09	438.59	98.10	22.22	20.50
Depreciation	1.22	115.52	10.79	4.74	3.51
EBIT	13.87	323.08	87.31	17.48	16.99
Interest	1.70	21.42	19.47	1.35	7.89
Other Income	0.29	126.93	5.70	0.54	0.35
Exceptional Items	--	-6.80	-0.99	--	--
Profit before Tax	12.47	427.47	72.55	16.67	9.45
Provision for Tax	3.71	106.74	16.83	4.38	2.76
Profit after Tax	8.75	320.73	55.72	12.29	6.69

Liabilities (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Shareholder's Funds	31.41	3,106.17	246.19	110.33	104.22
Minority Interest	--	43.07	--	--	--
Non-Current Liabilities	13.54	120.16	101.51	16.71	24.01
Current Liabilities	29.63	666.53	209.92	29.82	91.76
Total Liabilities	74.58	3,951.60	558.69	156.99	220.04

Assets (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Non-Current Assets	31.37	1,903.19	213.57	95.54	89.33
Current Assets	43.21	2,032.74	344.06	61.32	130.66
Total Assets	74.58	3,951.60	558.69	156.99	220.04
Total Debt*	28.93	341.62	225.48	25.45	90.92
Net Current Assets	13.58	1,366.21	134.14	31.50	38.91
Contingent Liabilities	0.37	50.21	52.55	5.27	1.05

Cashflow (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Cash From Operating Activities	5.91	246.37	16.38	--	18.77
Cash Flow from Investing Activities	-13.27	-225.38	-29.42	--	-18.27
Cash from Financing Activities	5.42	20.15	41.64	--	-0.78
Net Cash Inflow / Outflow	-1.95	41.14	28.60	0.00	-0.28

Ratios

Profitability Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
ROCE (%)	26.93	14.05	22.23	14.32	9.62
ROE (%)	32.37	10.94	25.55	11.80	6.96
ROA (%)	13.35	8.89	11.01	8.54	3.27
EBIT Margin (%)	29.30	30.16	30.37	19.70	13.69
Net Margin (%)	16.58	16.02	16.04	10.59	4.38
Cash Profit Margin (%)	19.00	23.12	18.40	12.56	6.70

Growth Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Revenue Growth (%)	16.07	12.30	9.13	24.96	5.13
EBIT Growth (%)	27.09	3.80	40.81	109.09	-12.29
Net Profit Growth (%)	23.30	-5.27	255.32	160.94	-35.79
EPS Growth (%)	23.30	-4.88	180.69	160.94	-40.73
Book Value Growth (%)	38.63	12.14	29.61	12.53	18.37

Valuation Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Price / Earnings	0.00	37.47	0.00	25.29	20.81
Price / Book Value	0.00	3.90	0.00	2.82	1.34
Dividend Yield (%)	--	0.29	--	0.00	0.69
EV/EBITDA	1.95	21.79	1.59	14.69	11.03
Market Cap (₹ Cr)	0.00	12,069.92	0.00	310.75	139.23

Solvency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Debt to Equity	0.92	0.11	0.92	0.23	0.87
Short term debt to equity ratio	0.45	0.08	0.36	0.03	0.60
Current Ratio	1.46	3.05	1.64	2.06	1.42
Quick Ratio	0.88	2.40	1.19	1.34	0.92
Interest Coverage	8.35	20.96	4.73	13.37	2.20

Operating Efficiency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Debtors to sales (%)	40.03	28.33	36.82	22.72	38.85
Asset Turnover	0.80	0.52	0.71	0.94	0.74
Receivable days	132.87	85.20	105.22	64.80	135.40
Inventory Days	105.13	69.58	93.48	56.27	102.09
Payable days	105.98	77.97	146.52	52.79	71.73
Cash Conversion Cycle	132.02	76.82	52.17	68.27	165.75